Tci Wealth Advisors, Inc. Krystal Biotech, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$72.39 - $84.27 $72 - $84	-1 Reduced 1.18%	84 $6,000
Q4 2022 Feb 06, 2023	BUY	$63.14 - $79.9 $63 - $79	1 Added 1.19%	85 $6,000
Q1 2022 Apr 29, 2022	SELL	$51.99 - $72.11 $363 - $504	-7 Reduced 7.69%	84 $6,000
Q4 2021 Jan 24, 2022	BUY	$39.81 - $88.24 $3,622 - $8,029	91 New	91 $6,000
Q3 2021 Oct 29, 2021	SELL	$52.01 - $71.77 $1,976 - $2,727	-38 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$62.14 - $81.82 $869 - $1,145	14 Added 58.33%	38 $3,000
Q1 2021 Apr 29, 2021	BUY	$59.42 - $85.46 $1,426 - $2,051	24 New	24 $2,000

310

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.57B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.